Michael Webb
Stanford University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Michael Webb.
British Journal of Sports Medicine | 2012
Chris M Bleakley; Philip Glasgow; Michael Webb
Ice is commonly used after acute muscle strains but there are no clinical studies of its effectiveness. By comparison, there are a number of basic scientific studies on animals which show that applying ice after muscle injury has a consistent effect on a number of important cellular and physiological events relating to recovery. Some of these effects may be temperature dependant; most animal studies induce significant reductions in muscle temperature at the injury site. The aim of this short report was to consider the cooling magnitudes likely in human models of muscle injury and to discuss its relevance to the clinical setting. Current best evidence shows that muscle temperature reductions in humans are moderate in comparison to most animal models, limiting direct translation to the clinical setting. Further important clinical questions arise when we consider the heterogenous nature of muscle injury in terms of injury type, depth and insulating adipose thickness. Contrary to current practice, it is unlikely that a ‘panacea’ cooling dose or duration exists in the clinical setting. Clinicians should consider that in extreme circumstances of muscle strain (eg, deep injury with high levels of adipose thickness around the injury site), the clinical effectiveness of cooling may be significantly reduced.
BMJ | 2017
Michael Webb; Saman Fahimi; Gitanjali Singh; Shahab Khatibzadeh; Renata Micha; John Powles; Dariush Mozaffarian
Objective To quantify the cost effectiveness of a government policy combining targeted industry agreements and public education to reduce sodium intake in 183 countries worldwide. Design Global modeling study. Setting 183 countries. Population Full adult population in each country. Intervention A “soft regulation” national policy that combines targeted industry agreements, government monitoring, and public education to reduce population sodium intake, modeled on the recent successful UK program. To account for heterogeneity in efficacy across countries, a range of scenarios were evaluated, including 10%, 30%, 0.5 g/day, and 1.5 g/day sodium reductions achieved over 10 years. We characterized global sodium intakes, blood pressure levels, effects of sodium on blood pressure and of blood pressure on cardiovascular disease, and cardiovascular disease rates in 2010, each by age and sex, in 183 countries. Country specific costs of a sodium reduction policy were estimated using the World Health Organization Noncommunicable Disease Costing Tool. Country specific impacts on mortality and disability adjusted life years (DALYs) were modeled using comparative risk assessment. We only evaluated program costs, without incorporating potential healthcare savings from prevented events, to provide conservative estimates of cost effectiveness Main outcome measure Cost effectiveness ratio, evaluated as purchasing power parity adjusted international dollars (equivalent to the country specific purchasing power of US
British Journal of Sports Medicine | 2017
H A P Archbold; Alan Rankin; Michael Webb; Richard Nicholas; N W A Eames; R.K. Wilson; L A Henderson; G J Heyes; Chris M Bleakley
) per DALY saved over 10 years. Results Worldwide, a 10% reduction in sodium consumption over 10 years within each country was projected to avert approximately 5.8 million DALYs/year related to cardiovascular diseases, at a population weighted mean cost of I
National Bureau of Economic Research | 2017
Nicholas Bloom; Charles I. Jones; John Van Reenen; Michael Webb
1.13 per capita over the 10 year intervention. The population weighted mean cost effectiveness ratio was approximately I
Archive | 2017
Ashkan Afshin; Renata Micha; Michael Webb; Simon Capewell; Laurie Whitsel; Adolfo Rubinstein; Dorairaj Prabhakaran; Marc Suhrcke; Dariush Mozaffarian
204/DALY. Across nine world regions, estimated cost effectiveness of sodium reduction was best in South Asia (I
BMJ | 2015
Pooler Archbold; Roger Wilson; Richard Nicholas; Niall Eames; Alan Rankin; Chris M Bleakley; Michael Webb
116/DALY); across the world’s 30 most populous countries, best in Uzbekistan (I
Case Reports | 2009
Chris M Bleakley; Philip Glasgow; Michael Webb; David Minion
26.08/DALY) and Myanmar (I
Archive | 2018
Michael Webb; Nick Short; Nicholas Bloom; Josh Lerner
33.30/DALY). Cost effectiveness was lowest in Australia/New Zealand (I
AEA Papers and Proceedings | 2018
Emanuele Colonnelli; Joacim Tåg; Michael Webb; Stefanie Wolter
880/DALY, or 0.02×gross domestic product (GDP) per capita), although still substantially better than standard thresholds for cost effective (<3.0×GDP per capita) or highly cost effective (<1.0×GDP per capita) interventions. Most (96.0%) of the world’s adult population lived in countries in which this intervention had a cost effectiveness ratio <0.1×GDP per capita, and 99.6% in countries with a cost effectiveness ratio <1.0×GDP per capita. Conclusion A government “soft regulation” strategy combining targeted industry agreements and public education to reduce dietary sodium is projected to be highly cost effective worldwide, even without accounting for potential healthcare savings.
The Spine Journal | 2017
Niall Eames; Lynn Murphy; S. McDonald; Michael Webb; Chris M Bleakley; Richard Nicholas; P. Archibold
Objective To examine injury patterns in adolescent rugby players and determine factors associated with injury risk. Design Prospective injury surveillance study. Setting N=28 Grammar Schools in Ulster, Ireland (2014–2015 playing season). Participants 825 adolescent rugby players, across in 28 school first XV rugby squads; mean age 16.9 years. Main outcome measures Injuries were classified by body part and diagnosis, and injury incidence using injuries per 1000 match hours of exposure. HRs for injury were calculated through Cox proportional hazard regression after correction for influential covariates. Results A total of n=426 injuries were reported across the playing season. Over 50% of injuries occurred in the tackle situation or during collisions (270/426), with few reported during set plays. The 3 most common injury sites were head/face (n=102, 23.9%), clavicle/shoulder (n=65, 15.3%) and the knee (n=56, 13.1%). Sprain (n=133, 31.2%), concussion (n=81, 19%) and muscle injury (n=65, 15.3%) were the most common diagnoses. Injury incidence is calculated at 29.06 injuries per 1000 match hours. There were no catastrophic injuries. A large percentage of injuries (208/424) resulted in absence from play for more than 28 days. Concussion carried the most significant time out from play (n=33; 15.9%), followed by dislocations of the shoulder (n=22; 10.6%), knee sprains (n=19, 9.1%), ankle sprains (n=14, 6.7%), hand/finger/thumb (n=11; 5.3%). 36.8% of participants in the study (304/825) suffered at least one injury during the playing season. Multivariate models found higher risk of injury (adjusted HR (AHR); 95% CI) with: higher age (AHR 1.45; 1.14 to 1.83), heavier weight (AHR 1.32; 1.04 to 1.69), playing representative rugby (AHR 1.42; 1.06 to 1.90) and undertaking regular strength training (AHR 1.65; 1.11 to 2.46). Playing for a lower ranked team (AHR 0.67; 0.49 to 0.90) and wearing a mouthguard (AHR 0.70; 0.54 to 0.92) were associated with lower risk of injury. Conclusions There was a high incidence of severe injuries, with concussion, ankle and knee ligament injuries and upper limb fractures/dislocations causing greatest time loss. Players were compliant with current graduated return-to-play regulations following concussion. Physical stature and levels of competition were important risk factors and there was limited evidence for protective equipment.